Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel
Clinical trial NCT03566576 · UNKNOWN
Trial details
- NCT number
- NCT03566576
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2018-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.